Home » Topics » Conferences

Conferences
RSS

ETA antagonism with LU-135252 may provide novel antiischemic therapy

Aug. 28, 1998

Contrast agent from Nycomed Imaging proves useful for several applications

Aug. 28, 1998

AR-C69931MX; a novel P2T antagonist with platelet aggregation-inhibitory activity

Aug. 28, 1998

Glaxo Wellcome presents development candidate GW-311616A

Aug. 27, 1998

New agent for the prevention of osteoarthritis identified at Roche Bioscience

Aug. 27, 1998

Bristol-Myers Squibb program on beta3-adrenoceptor agonists outlined at ACS

Aug. 27, 1998

MMP inhibitors under investigation at Pharmacia & Upjohn

Aug. 27, 1998

News from the ACS: LTB4 antagonists for diagnostic use

Aug. 27, 1998

A-131701: a uroselective alpha-adrenergic agent for treatment of BPH

Aug. 27, 1998

GG-745: a 5alpha-reductase inhibitor with significant advantages over finasteride

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026